These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33356546)

  • 21. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.
    Genvigir FD; Rodrigues AC; Cerda A; Arazi SS; Willrich MA; Oliveira R; Hirata MH; Dorea EL; Bernik MM; Curi R; Hirata RD
    Pharmacogenomics; 2010 Sep; 11(9):1235-46. PubMed ID: 20860464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
    Hunninghake DB; Ballantyne CM; Maccubbin DL; Shah AK; Gumbiner B; Mitchel YB
    Clin Ther; 2003 Jun; 25(6):1670-86. PubMed ID: 12860491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the comparative effects of hawthorn fruit compound and simvastatin on lowering blood lipid levels.
    Xu H; Xu HE; Ryan D
    Am J Chin Med; 2009; 37(5):903-8. PubMed ID: 19885950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S; Guyton JR; Polis AB; Adewale AJ; Tomassini JE; Ryan NW; Tershakovec AM
    Am J Cardiol; 2010 Feb; 105(4):487-94. PubMed ID: 20152243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia.
    Li J; Wang X; Zhang Z; Zou J; Chen Y; Wang X; Wu J
    Curr Med Res Opin; 2014 Feb; 30(2):223-8. PubMed ID: 24156754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
    Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
    Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological function of ABCG1.
    Ito T
    Drug News Perspect; 2003 Oct; 16(8):490-2. PubMed ID: 14668945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
    Rader DJ; Davidson MH; Caplan RJ; Pears JS
    Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
    Fukuo Y; Nagashima M; Saitoh A; Kobayashi Y; Terashi A; Nakama K; Kameyama K; Asano G
    Clin Ther; 1991; 13(3):417-24. PubMed ID: 1954642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of apolipoprotein B and E gene polymorphisms on the response to simvastatin therapy in patients with hyperlipidemia.
    Ye P; Shang Y; Ding X
    Chin Med Sci J; 2003 Mar; 18(1):9-13. PubMed ID: 12901521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
    Pirat B; Korkmaz ME; Eroğlu S; Tayfun E; Yildirir A; Uluçam M; Ozin B; Müderrisoğlu H
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):318-22. PubMed ID: 15590360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study.
    Sayols-Baixeras S; Subirana I; Lluis-Ganella C; Civeira F; Roquer J; Do AN; Absher D; Cenarro A; Muñoz D; Soriano-Tárraga C; Jiménez-Conde J; Ordovas JM; Senti M; Aslibekyan S; Marrugat J; Arnett DK; Elosua R
    Hum Mol Genet; 2016 Oct; 25(20):4556-4565. PubMed ID: 28173150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A; Stancáková A; Javorský M; Tkác I
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.